4.7 Article

Effect of a Dietary Portfolio of Cholesterol-Lowering Foods Given at 2 Levels of Intensity of Dietary Advice on Serum Lipids in Hyperlipidemia A Randomized Controlled Trial

期刊

出版社

AMER MEDICAL ASSOC
DOI: 10.1001/jama.2011.1202

关键词

-

资金

  1. Loblaw Brands Ltd
  2. Unilever
  3. Barilla
  4. Almond Board of California
  5. Solae
  6. Haine Celestial
  7. Sanitarium Company
  8. Orafti
  9. International Tree Nut Council
  10. Peanut Institute
  11. Canadian Institutes of Health Research (CIHR)
  12. Canada Research Chair Endowment (CRCE) of the Federal Government of Canada
  13. Advanced Foods and Materials Network (AFM Net)
  14. Danone
  15. Enzymotec
  16. CRCE of the Federal Government of Canada
  17. Viterra Food Processing-Oat and Specialty Grain Milling
  18. St Michael's Hospital Foundation
  19. Unilever (Vlaardingen, the Netherlands)
  20. Unilever (Toronto, Ontario, Canada)

向作者/读者索取更多资源

Context Combining foods with recognized cholesterol-lowering properties (dietary portfolio) has proven highly effective in lowering serum cholesterol under metabolically controlled conditions. Objective To assess the effect of a dietary portfolio administered at 2 levels of intensity on percentage change in low-density lipoprotein cholesterol (LDL-C) among participants following self-selected diets. Design, Setting, and Participants A parallel-design study of 351 participants with hyperlipidemia from 4 participating academic centers across Canada (Quebec City, Toronto, Winnipeg, and Vancouver) randomized between June 25, 2007, and February 19, 2009, to 1 of 3 treatments lasting 6 months. Intervention Participants received dietary advice for 6 months on either a low-saturated fat therapeutic diet (control) or a dietary portfolio, for which counseling was delivered at different frequencies, that emphasized dietary incorporation of plant sterols, soy protein, viscous fibers, and nuts. Routine dietary portfolio involved 2 clinic visits over 6 months and intensive dietary portfolio involved 7 clinic visits over 6 months. Main Outcome Measures Percentage change in serum LDL-C. Results In the modified intention-to-treat analysis of 345 participants, the overall attrition rate was not significantly different between treatments (18% for intensive dietary portfolio, 23% for routine dietary portfolio, and 26% for control; Fisher exact test, P=.33). The LDL-C reductions from an overall mean of 171 mg/dL (95% confidence interval [CI], 168-174 mg/dL) were -13.8% (95% CI, -17.2% to -10.3%; P<.001) or -26 mg/dL (95% CI, -31 to -21 mg/dL; P<.001) for the intensive dietary portfolio; -13.1% (95% CI, -16.7% to -9.5%; P<.001) or -24 mg/dL (95% CI, -30 to -19 mg/dL; P<.001) for the routine dietary portfolio; and -3.0% (95% CI, -6.1% to 0.1%; P=.06) or -8 mg/dL (95% CI, -13 to -3 mg/dL; P=.002) for the control diet. Percentage LDL-C reductions for each dietary portfolio were significantly more than the control diet (P<.001, respectively). The 2 dietary portfolio interventions did not differ significantly (P=.66). Among participants randomized to one of the dietary portfolio interventions, percentage reduction in LDL-C on the dietary portfolio was associated with dietary adherence (r=-0.34, n=157, P<.001). Conclusion Use of a dietary portfolio compared with the low-saturated fat dietary advice resulted in greater LDL-C lowering during 6 months of follow-up.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据